Innovation & intellectual property · 21/05/2003Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for Ranolazine Patent
Summary
The U.S. Patent and Trademark Office has issued a certificate for a one-year extension of the term of U.S. Patent No. 4,567,264, which covers the medication ranolazine.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →